Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Total Non-Current Liabilities (2019 - 2025)

Volitionrx (VNRX) has disclosed Total Non-Current Liabilities for 9 consecutive years, with $31.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Non-Current Liabilities rose 514.48% year-over-year to $31.0 million, compared with a TTM value of $31.0 million through Sep 2025, up 514.48%, and an annual FY2024 reading of $27.7 million, up 474.36% over the prior year.
  • Total Non-Current Liabilities was $31.0 million for Q3 2025 at Volitionrx, down from $32.6 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $32.6 million in Q2 2025 and bottomed at -$31.4 million in Q1 2021.
  • Average Total Non-Current Liabilities over 5 years is $12.9 million, with a median of $9.5 million recorded in 2021.
  • The sharpest move saw Total Non-Current Liabilities tumbled 524.88% in 2021, then soared 552.55% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $9.5 million in 2021, then tumbled by 57.58% to $4.0 million in 2022, then increased by 19.57% to $4.8 million in 2023, then surged by 474.36% to $27.7 million in 2024, then grew by 11.76% to $31.0 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for VNRX at $31.0 million in Q3 2025, $32.6 million in Q2 2025, and $29.3 million in Q1 2025.